Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein–Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma

Figure 2

Representative PET reconstructions showing partial response after 6 cycles of R-CHOP (a), disease persistence following second line therapy (b), and complete metabolic response after brentuximab-nivolumab (c).